Trump administration weighs Marshall for FDA as Overton wobbles
But the Trump administration official said Diamantas — who did not want the top job on a permanent basis — is eyeing a departure from FDA regardless of what happens with Overton’s nomination.
- Republicans face a severe time crunch if Overton’s nomination is pulled or fails in committee; they have a month and a half left in the majority to confirm President Donald Trump’s nominees.
- The Kansas Republican, who just lost his reelection bid, is seen as a stronger potential nominee than Overton, who faces opposition from both anti-abortion activists and moderate Republicans in her bid to lead the agency.
- “There is a growing view in the Senate that a senator would be the only person while we’ve got a majority so Roger Marshall’s name is quickly percolating as a person who would be confirmable,” said a senior Republican aide.
Roger Marshall as a potential replacement nominee to lead the Food and Drug Administration as Heidi Overton’s confirmation struggles in the Senate, according to four people familiar with the matter.
“Marshall is viewed as an alternative if Heidi can’t make it through,” a Trump administration official told Semafor.
- Kyle Diamantas, a lawyer who worked as the agency’s top food official, was tapped as acting FDA commissioner and earned a reputation as a competent leader who helped stabilize the agency.
- The FDA has operated under acting leadership since former Commissioner Marty Makary was pushed out in May after clashing with the White House over whether to authorize flavored vapes.
- Notable If Marshall had defeated Kansas Democratic Sen.-elect Adam Hamilton this month, he may have been in line to take the health committee’s top GOP spot, as Semafor reported.
- No final decision has been made on abandoning Overton, though there’s quiet acknowledgment internally that her path to confirmation is exceedingly difficult.
- At this point, it’s hard to get anyone approved.” The Senate health committee is scheduled to vote on Overton’s nomination on Wednesday.
How this summary was made: extractive summary — built from the sources' own reporting. It is drawn only from the reporting of the sources listed below — read the originals for full detail. How we summarize →